कृपया अन्य खोज का प्रयास करें
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; urea breath test kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment sells medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Other Businesses segment provides independent clinical laboratory services for nuclear technology industry applications and medical product applications; and sells radiation therapy equipment and other miscellaneous services. In addition, the company engages in the production and sale of bio-pharmaceuticals. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Guoping Zhang | 51 | 2019 | Supervisor |
Zhonglin Liu | 54 | 2021 | Chairman of the Board of Supervisors |
Jingshan Chen | 53 | 2021 | Independent Non-Executive Director |
Qihui Peng | 30 | 2022 | Employee Representative Supervisor |
Fuxin Ma | 32 | 2022 | Employee Representative Supervisor |
Chuang Lu | 44 | 2021 | Independent Non-Executive Director |
Nanfei Zhao | 43 | 2021 | Supervisor |
Jinyu Chang | 52 | 2019 | Non Executive Director |
Jiahe Tian | 73 | 2019 | Independent Non-Executive Director |
Jianmin Ding | 51 | 2023 | Non-Executive Director |
Chiu Kwok Poon | 62 | 2023 | Independent Non-Executive Director |
Xiuhong Liu | 57 | 2020 | Non-Executive Director |
Junqi Zhang | 52 | 2023 | Executive Chairman |
Guomin Fan | 53 | 2023 | Deputy GM & Executive Director |
Yao Wang | - | 2024 | Executive Director |
Shoulei Chen | 58 | 2017 | Vice Chairman of the Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है